AbbVie company profile

ABBV · NYSE · USD

Compare AbbVie
$292.82Change from previous close: −0.59%Absolute change: −$1.73

Close · November 17, 2026

Company profile

AbbVie has 57,000 employees and is headquartered in North Chicago, United States.

The United States accounts for 76.2% of the sales of AbbVie Inc., while other countries contribute 9.4%, and Germany, Japan, Canada, China, France and the United Kingdom each represent between 1.0% and 2.8%. The company researches, develops, manufactures and sells medicines and therapies worldwide. Its main products include Skyrizi and Rinvoq for autoimmune and inflammatory diseases, Imbruvica, Venclexta and Epkinly for blood cancers, Vraylar for psychiatric disorders, Ubrelvy and Qulipta for migraine, Mavyret for hepatitis C, and Creon, a pancreatic enzyme therapy. It also sells aesthetic brands such as Botox Cosmetic and Juvederm, along with eye care products including Ozurdex.

In the fiscal year ended December 2025, AbbVie reported revenue of $61.2 billion, up 8.6% from the previous year, and net income of $4.2 billion. The company employs 57,000 people and is headquartered in North Chicago, Illinois. It was incorporated in 2012.

Company facts

Industry
Drug Manufacturers - General
Headquarters
1 North Waukegan Road, 60064-6400, North Chicago
Employees
57,000
Chief executive
Robert Michael
Founded
2012
Fiscal year
January - December
Listing
ABBV · NYSE
Indices
S&P 500
Currency
USD
ISIN
US00287Y1091
Website
abbvie.com

AbbVie and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
AbbVieABBVUnited States$517.59B57,00036.6%50.4
Johnson & JohnsonJNJUnited States$680.19B138,20026.6%42.9
Merck & Co.MRKUnited States$356.13B73,00035.2%144.5
AmgenAMGNUnited States$250.07B31,50034.1%26.8
Gilead SciencesGILDUnited States$211.18B17,00038.2%—
Eli LillyLLYUnited States$1.28T50,00051.3%46.5

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare AbbVie with its competitors